Official company source

The First Phase 3 Obesity Study of Retatrutide in People with Obesity (TRIUMPH-1).

Eli Lilly and Company. The First Phase 3 Obesity Study of Retatrutide in People with Obesity (TRIUMPH-1). ADA Scientific Sessions presentation, 2026-06-06.

Eli Lilly and CompanyPublished 2026-06-06Accessed 2026-07-12

Open original source

Registry record

Source metadata

Publisher: Eli Lilly and Company
Source type: Official company source
Registry ID: research-reta-05
Source code: RETA-05

Source usage

Linked from 1 page

Compound

Retatrutide

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.